GISAID
GISAID is open-access to genetic data of influenza viruses,[3] and the coronavirus responsible for the COVID-19 pandemic.[4][5]
| GISAID Initiative | |
|---|---|
| Abbreviation | GISAID |
| Formation | May 2008 |
| Type | Nonprofit organization Public–private partnership |
| Purpose/focus | Global health, research, education |
| Headquarters | Munich, Germany |
| Key people | |
On January 10, 2020, the first whole-genome sequences of SARS-CoV-2 were made available on GISAID. This enabled global responses to the pandemic.[6] There was the first vaccines,[7] and diagnostic tests,[8] to detect SARS-CoV-2. GISAID helps watch for the emergence of new COVID-19 viral strains across the planet.[6][9]
Its establishment was an alternative to sharing avian influenza data by conventional public-domain archives.[10][3][11] GISAID has given rapid exchange of outbreak data[11] during the H1N1 pandemic[12][13] in 2009, the H7N9 epidemic[14][15] in 2013, and the COVID-19 pandemic[16][17] in 2020.
GISAID was recognized for its importance to world health by G20 health ministers in 2017,[18] and in 2020 the World Health Organization chief scientist called the data-science initiative "a game changer".[4]
GISAID Media
GISAID Founder Peter Bogner and German State Secretary Robert Kloos
Related pages
References
- ↑ huaxia (November 1, 2019). Chinese experts call for global cooperation in flu prevention. Xinhua News Agency. http://www.xinhuanet.com/english/2019-11/01/c_138521324.htm. Retrieved July 7, 2020.
- ↑ "Governance & Expertise: Scientific Advisory Council". GISAID. 2020. Retrieved July 7, 2020.
The Scientific Advisory Council (SAC) comprises leading influenza scientists with expertise in epidemiology, human and veterinary virology and bioinformatics.
- ↑ 3.0 3.1 Shu, Yuelong; McCauley, John (2017). "GISAID: Global initiative on sharing all influenza data – from vision to reality". Eurosurveillance. 22 (13). doi:10.2807/1560-7917.ES.2017.22.13.30494. PMC 5388101. PMID 28382917.
- ↑ 4.0 4.1 Swaminathan, Soumya (December 17, 2020). "The WHO's chief scientist on a year of loss and learning". Nature. https://www.nature.com/articles/d41586-020-03556-y. Retrieved December 20, 2020.
- ↑ Korber, Bette (August 20, 2020). "Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus". Cell. 182 (4): 812–827.e19. doi:10.1016/j.cell.2020.06.043. PMC 7332439. PMID 32697968.
the global sampling of SARS-CoV-2 is being very capably addressed by the Global Initiative for Sharing All Influenza Data (GISAID) database
- ↑ 6.0 6.1 "CEPI's collaborative task force to assess COVID-19 vaccines on emerging viral strains". BioSpectrum - Asia Edition. November 23, 2020. https://www.biospectrumasia.com/news/83/17161/cepis-collaborative-task-force-to-assess-covid-19-vaccines-on-emerging-viral-strains.html. Retrieved December 24, 2020. "GISAID is an essential component of COVID-19 R&D that enables real-time progress in the understanding of the geographical spread, circulation, and evolution of the SARS-CoV-2 virus".
- ↑ Polack, Fernando (December 10, 2020). "Safety and Efficacy of the mRNA Covid-19 Vaccine". New England Journal of Medicine. 383 (27): 2603–2615. doi:10.1056/NEJMoa2034577. PMC 7745181. PMID 33301246.
The development of BNT162b2 was initiated on January 10, 2020, when the SARS-CoV-2 genetic sequence was released by the Chinese Center for Disease Control and Prevention and disseminated globally by the GISAID (Global Initiative on Sharing All Influenza Data) initiative.
- ↑ Bohn, Mary Kathryn (October 7, 2020). "IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection". Clinical Chemistry and Laboratory Medicine. 58 (12): 1993–2000. doi:10.1515/cclm-2020-1412. PMID 33027042.
- ↑ Jameel, Shahid (2 April 2020). "Coronavirus pandemic highlights key need for science and partnerships". The Telegraph (Kolkata). Retrieved 29 December 2020.
- ↑ McDowell, Robin (May 15, 2008). "Indonesia hands over bird flu data to new database". Fox News. https://www.foxnews.com/printer_friendly_wires/2008May15/0,4675,BirdFluNewDatabase,00.html. Retrieved June 7, 2020.
- ↑ 11.0 11.1 Elbe, Stefan; Buckland-Merrett, Gemma (January 10, 2017). "Data, disease and diplomacy: GISAID's innovative contribution to global health". Global Challenges. 1 (1): 33–46. Bibcode:2017GloCh...1...33E. doi:10.1002/gch2.1018. PMC 6607375. PMID 31565258.
- ↑ Schnirring, Lisa (June 25, 2009). "Pandemic reveals strengths of new flu database". Center for Infectious Disease Research and Policy. https://www.cidrap.umn.edu/news-perspective/2009/06/pandemic-reveals-strengths-new-flu-database. Retrieved June 7, 2020.
- ↑ "Viral gene sequences to assist update diagnostics for swine influenza A(H1N1)" (PDF). World Health Organization. April 25, 2009. Retrieved June 7, 2020.
- ↑ "The fight against bird flu". Nature. 496 (7446): 397. April 24, 2013. doi:10.1038/496397a. PMID 23627002.
- ↑ Larson, Christina (April 10, 2013). "CDC Races to Create a Vaccine for China's Latest Bird Flu Strain". Bloomberg BusinessWeek. https://www.bloomberg.com/news/articles/2013-04-10/cdc-races-to-create-a-vaccine-for-chinas-latest-bird-flu-strain. Retrieved June 7, 2020.
- ↑ Prasad, R. (January 19, 2020). "What is the source of the new SARS-like disease reported in China?". The Hindu. https://www.thehindu.com/sci-tech/health/coronavirus-alert/article30595786.ece. Retrieved June 7, 2020.
- ↑ Ng, Kang-chung (January 12, 2020). "Wuhan pneumonia: Hong Kong set to develop new test for mystery virus after obtaining genetic sequence from mainland China". South China Morning Post. https://www.scmp.com/news/hong-kong/health-environment/article/3045750/wuhan-pneumonia-hong-kong-set-develop-new-test. Retrieved June 7, 2020.
- ↑ Health Ministers (20 May 2017). "Berlin Declaration of the G20 Health Ministers" (PDF). German Ministry of Health. Retrieved 18 July 2017.